Prelude Therapeutics PRLD
NASDAQ PRLD
$3.96 +0.05 (+1.28%)
At close: Sep 29, 2026 · 4:00 PM EDT

Prelude Therapeutics (PRLD) Current Leases (2019 - 2025)

Updated

Prelude Therapeutics (PRLD) posted Current Leases of $53,000 for Q1 2025, down 74.5% from the prior quarter.

Analysis

Prelude Therapeutics (PRLD) Current Leases (2019 - 2025) Analysis & Trends

At the end of FY2024, Prelude Therapeutics' Current Leases came in at $208,000.

  • Annual Current Leases shows a five-year compound annual growth rate of -4.2% (FY2019 to FY2024).
  • According to Business Quant data, Current Leases for the three prior quarters was $208,000 (Q4 2024), $359,000 (Q3 2024) and $507,000 (Q2 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Prelude Therapeutics 312.03 Mn -285.27 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 53,000.00
Dec 31, 2024 208,000.00
Sep 30, 2024 359,000.00
Jun 30, 2024 507,000.00
Dec 31, 2019 258,000.00
API Access

Prelude Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=PRLD&period=max&api_key=YOUR_API_KEY